ALTERITY THERAPEUTICS-ADR (ATHE) Earnings History & Surprises

NASDAQ:ATHE • US02155X2053

Current stock price

3.715 USD
-0.13 (-3.38%)
Last:

ATHE Earnings overview

Past quarterly earnings results for ALTERITY THERAPEUTICS-ADR (ATHE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A

Last Reported

Most Recent
Release Date
Feb 26, 2026
Period
Q2 / 2026
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in AUD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2026 - - 909.8K - 717.43%
Q4 2025 - - 335K - 123.33%
Q2 2025 - - 111.3K - -6.00%
Q4 2024 - - 150K - 2,841.18%
Q2 2024 - - 118.4K - 938.60%
Q4 2023 - - 5.1K - 325.00%
Q2 2023 - - 11.4K - 714.29%
Q4 2022 - - 1.2K - -91.49%
Q2 2022 - - 1.4K - -78.79%
Q4 2021 - - 14.1K - 370.00%
Q2 2021 - - 6.6K - -53.19%
Q4 2020 - - 3K - -
Q2 2020 - - 14.1K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

ATHE Revenue Q2Q GrowthATHE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 0 500 1K 1.5K 2K 2.5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

ATHE Overview ATHE Technical Analysis Report ATHE Fundamental Analysis Report ATHE Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ALTERITY THERAPEUTICS-ADR / ATHE Earnings FAQ

What is the most recent earnings date for ATHE stock?

ALTERITY THERAPEUTICS-ADR (ATHE) last reported earnings on 2/26/2026.

Did ALTERITY THERAPEUTICS-ADR (ATHE) beat earnings estimates last quarter?

ALTERITY THERAPEUTICS-ADR (ATHE) missed EPS estimates and missed revenue estimates in the most recent quarter.